Seongseok Yun, MD, PhD¹, Nicole D. Vincelette, PhD¹, Mario Fernandez^2*, Xiaoqing Yu, PhD^3*, Chunying Yang^4*, Taro Hitosugi, PhD^5*, Chia-Ho Cheng, Ph.D.^2*, Audrey Freischel^6*, Ling Zhang, MD^7*, Gregory Watson, PhD^1*, Weimin Li^8*, Hsin-An Hou, MD, PhD^9*, Franz Xaver Schaub, PhD^6*, Alexis Vedder, BS^1*, Ling Cen, PhD^10*, Kathy McGraw, PhD¹¹, Daniel Murphy, PhD^12*, Andrea Ballabio^13*, Scott H. Kaufmann, MD, PhD^14*, Anders Berglund^15* and John L. Cleveland, PhD²

¹Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
²H. Lee Moffitt Cancer Center, Tampa, FL
³Bioinformatics and Biostatistics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
⁴Moffitt Cancer Center, Tampa, FL
⁵Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN
⁶H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
⁷Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁸H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
⁹Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
¹⁰Bioinformatics, H. Lee Moffitt Cancer Center, Tampa, FL
¹¹H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
¹²University of Glasgow, Institute of Cancer Sciences, Cancer Research UK Beatson Institute, Glasgow, United Kingdom
¹³Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy
¹⁴Division of Hematology, Mayo Clinic, Rochester, MN
¹⁵Moffitt Cancer Center, TAMPA

Julio Castaño, PhD^1*, Francesca De Giorgio, PhD^2*, Francesca Lessi, PhD^3*, Paolo Aretini, PhD^3*, Chiara Maria Mazzanti, PhD^3*, Loris Mularoni, PhD^2*, Jessica Gonzalez, PhD^4*, Emilia J. Kozyra, MSc^5*, Albert Catalá, MD PhD^6*, Jose Carlos Rodriguez-Gallego, MD, PhD^7*, Josep F Nomdedeu, MD^8*, Cristina Díaz de Heredia, MD, PhD^9*, Antonio Perez Martinez, MD, PhD^10*, Adela Escudero-Lopez, MD, PhD^11*, Félix López Cadenas, MD^12*, Maria Diez-Campelo, PhD, MD^13*, Teresa González, MD^14*, Carolina Martínez-Laperche, PhD^15*, Nieves Dorado, MD^16*, Francisco Marco, MD, PhD^17*, Csaba Bodor, PhD^18*, Marcin Wlodarski, MD, PhD¹⁹, Anna Bigas, PhD^20* and Alessandra Giorgetti, PhD^21,22*

¹Immunotherapy Unit, Banc de Sang i Teixits, Barcelona, Spain
²Clinical Translational Program for Regenerative Medicine in Catalonia, Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet Llobregat, Spain
³Fondazione Pisana Per La Scienza ONLUS, Pisa, Italy
⁴Cancer Research Program, Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Barcelona, Spain
⁵University Childrens Hospital Freiburg, Freiburg, Germany
⁶Servicio de Hematologia y Oncologia, Hospital Sant Joan de Deu and CIBERER, Barcelona, Spain
⁷Servicio de Inmunología, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas, Spain
⁸Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
⁹Pediatric Oncology and Hematology Department, Hospital Universitari Vall d’Hebron Vall d’Hebron, Barcelona, Spain
¹⁰Hospital Infantil Universitario Niño Jesús, Madrid, ESP
¹¹Molecular Pediatric Oncology Unit, nstitute of Medical and Molecular Genetics (INGEMM), Hospital Universitario La Paz, Madrid, Spain
¹²Departamento de Hematología, Hospital Clínico Universitario de Salamanca (CAUSA/IBSAL), Salamanca, Spain
¹³Hematology Department, Hospital Clínico Universitario de Salamanca (CAUSA/IBSAL), Salamanca, Spain
¹⁴Hematology Department, Hospital Universitario de Salamanca., Salamanca, Spain
¹⁵Gregorio Marañón Health Research Institute (IiSGM), Madrid, Spain
¹⁶Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
¹⁷Biotecnología, Universidad de Alicante, Alicante, Spain
¹⁸Semmelweis University, Budapest, Hungary
¹⁹Department of Pediatrics and Adolescent Medicine, University Medical Center Freiburg, Freiburg, Germany
²⁰IMIM - Hospital Del Mar Research Institute, Barcelona, ESP
²¹Fondazione Pisana per la Scienza (FPS), Pisa, Italy
²²Translational Program for Regenerative Medicine in Catalonia, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet De Llogregat (barcelona), Spain

Gloria Mas Martin, PhD^1*, Na Man^1*, Daniel Karl, PhD^2*, Concepcion Martinez, B.S.^1*, Stephanie Duffort^1*, Hidehiro Itonaga, MD, PhD^1,3*, Adnan K Mookhtiar, BS^4*, Daniel Bilbao, PhD¹, Kranthi Kunkalla^5*, Alfredo M Valencia^6*, Clayton Collings^7*, Cigall Kadoch, PhD^8*, Francisco Vega, MD, PhD⁹, Scott C. Kogan, MD¹⁰ and Stephen Nimer, MD¹¹

¹Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
²Biostatistics and Bioinformatics shared resource, Department of Human Genetics, University of Miami Miller School of Medicine, Miami, FL
³Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan
⁴Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL
⁵Division of Hematopathology, Department of Pathology and Laboratory Medicine, University of Miami/Sylvester Comprehensive Cancer Center, Miami, FL
⁶Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
⁷Broad Institute of MIT and Harvard, Cambridge, MA
⁸Dana-Farber Cancer Institute, Boston, MA
⁹MD Anderson Cancer Center, University of Texas, Texas, TX
¹⁰Univ. of CA, San Francisco, San Francisco, CA
¹¹Sylvester Comprehensive Cancer Center, Miami, FL

Kevin Nuno, BS^1*, Armon Azizi, BS^1*, Thomas Koehnke, MD¹, M. Ryan Corces, PhD^2,3 and Ravi Majeti¹

¹Department of Medicine, Division of Hematology, Cancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA
²Department of Medicine, Division of Hematology, Stanford University, Stanford, CA
³Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA

Daphne Dupere-Richer, PhD¹, Sayantan Maji, Ph.D^2*, Alberto Riva, PhD^1*, Gabrielle Quickstad^2*, Marta Kulis^3*, Darby Monagle^2*, José I. Martín-Subero, PhD^4*, Richard Lynn Bennett, PhD¹ and Jonathan D. Licht, MD²

¹Cancer and Genetics Research Complex, University of Florida, Gainesville, FL
²Department of Medicine, University of Florida, Gainesville, FL
³Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
⁴Departamento de Fundamentos Clínicos, IDIBAPS, Barcelona, Spain

Qingqing Cai, PhD^1*, Ning Su, MM^1*, Yu Fang, BMBS^1*, Xu Chen, MD, PhD^2*, Xiaopeng Tian, MD, PhD^1*, Shuyun Ma, MM^1*, Xiaoqin Chen, MD, PhD^3*, Zhongjun Xia, MD, PhD³, Tongyu Lin, MD, PhD^1*, Huiqiang Huang, MD, PhD¹, Zhiming Li, MD, PhD^1*, Xueyi Pan, MD, PhD^4*, Yi Xia, MD, PhD^1*, Panpan Liu, MD, PhD^1*, Xuanye Zhang, MD, PhD^1*, Hang Yang, MD, PhD^1* and Stephen Yang Liang, MD, PhD³

¹Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
²Department of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China
³Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
⁴Department of Hematology, First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China

Jia Li, PhD^1*, Yue Wei, PhD², Minjung Lee^1*, Hui Yang, MD, PhD², Caleb Class, PhD^3*, Stefan Siwko^4*, Yubin Zhou, PhD^5*, Deqiang Sun, PhD^1*, Guillermo Garcia-Manero, MD⁶ and Yun Huang, PhD^7,8

¹Center for Epigenetics and Disease Prevention, Institute of Biosciences and Technology, Texas A&M University, Houston, TX
²Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX
⁴Texas A&M University, Hoston, TX
⁵Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, TX
⁶Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Institute of Biosciences and Technology, Texas A&M University, College of Medicine, Houston
⁸Center for Epigenetics & Disease Prevention, Institute of Biosciences and Technology, Texas A&M University, Houston, TX

Ya Zhang, MD^1,2*, Xinting Hu, MM^1,2*, Hongzhi Xu, MD^1,2*, Ying Li, MD^1*, Lingyan Zhang, MD^1,2*, Lili Feng, MD^1*, Xiangxiang Zhou, MD^1,2*, Xiaosheng Fang, MD, PhD^1,2*, Yujie Jiang, MD^1,2, Mei Ding, MD^1,2*, Jianhong Wang^1,2* and Xin Wang, MD, PhD^1,2

¹Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China
²Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China